Lv11
50 积分 2024-07-09 加入
BL-B01D1, a first-in-class EGFR–HER3 bispecific antibody–drug conjugate, in patients with locally advanced or metastatic solid tumours: a first-in-human, open-label, multicentre, phase 1 study
2小时前
已完结
Structural insights into the role of SHOC2-MRAS-PP1C complex in RAF activation
2个月前
已完结
The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity
2个月前
已完结
From bench to bedside: current development and emerging trend of KRAS-targeted therapy
2个月前
已完结
Dose Range Finding (DRF) Studies in Drug Toxicology Assessments
3个月前
已关闭
8种人胰腺癌细胞株常见肿瘤相关基因突变特征分析
4个月前
已完结
皖公网安备34019202002308
